Organisation for Economic Co-operation and Development (OECD). Urgent action needed to address growing opioid crisis. 2019. https://www.oecd.org/canada/urgent-action-needed-to-address-growing-opioid-crisis.htm. Accessed 5 Mar 2020.
Canadian Centre on Substance Use and Addiction (CCSA). Canadian Drug Summary: Opioids. 2022. https://www.ccsa.ca/opioids-canadian-drug-summary. Accessed 28 Nov 2022.
American Geriatrics Society. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767.
Canadian Institute for Health Information (CIHI). Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada. 2016. https://secure.cihi.ca/free_products/Opioid%20Poisoning%20Report%20%20EN.pdf. Accessed 27 July 2022.
D'Aiuto C, Lunghi C, Guénette L, Berbiche D, Bertrand K, Vasiliadis HM. Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada. BMC Health Serv Res. 2023;23(1):1295. https://doi.org/10.1186/s12913-023-10303-2.
Corsonello A, Pedone C, Antonelli IR. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17(6):571–84. https://doi.org/10.2174/092986710790416326.
Article CAS PubMed Google Scholar
Kwan D, Farrell B. Polypharmacy: optimizing medication use in elderly patients. Can Geriatr Soc J CME. 2014;4(1):7.
McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163–84. https://doi.org/10.1124/pr.56.2.4.
Article CAS PubMed Google Scholar
Government of Canada, Statistics Canada. Older adults and population aging statistics. Statcan. 2019. https://www.statcan.gc.ca/en/subjects-start/older_adults_and_population_aging. Accessed 24 Jan 2022.
Ray WA, Chung CP, Murray KT, Malow BA, Daugherty JR, Stein CM. Mortality and concurrent use of opioids and hypnotics in older patients: a retrospective cohort study. PLoS Med. 2021;18(7): e1003709. https://doi.org/10.1371/journal.pmed.1003709.
Article CAS PubMed PubMed Central Google Scholar
Rose AJ, McBain R, Schuler MS, et al. Effect of age on opioid prescribing, overdose, and mortality in Massachusetts, 2011 to 2015. J Am Geriatr Soc. 2019;67(1):128–32. https://doi.org/10.1111/jgs.15659.
Sharma V, Simpson SH, Samanani S, Jess E, Eurich DT. Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study. BMJ Open. 2020;10(11): e038692. https://doi.org/10.1136/bmjopen-2020-038692.
Article PubMed PubMed Central Google Scholar
Chin MH, Wang LC, Jin L, et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med. 1999;6(12):1232–42. https://doi.org/10.1111/j.1553-2712.1999.tb00139.x.
Article CAS PubMed Google Scholar
Perri M III, Menon AM, Deshpande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother. 2005;39(3):405–11. https://doi.org/10.1345/aph.1E230.
Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol. 1995;48(8):999–1009. https://doi.org/10.1016/0895-4356(94)00234-h.
Article CAS PubMed Google Scholar
Government of Canada. MED-ÉCHO—S14 Report—interregional mobility, hospital days by region, treatment and residence. 2023. https://open.canada.ca/data/en/dataset/f8b8190b-c63d-41ca-bbc3-8f494092c4bc. Accessed 22 Feb 2024.
Préville M, Mechakra-Tahiri SD, Vasiliadis HM, et al. Family violence among older adult patients consulting in primary care clinics: results from the ESA (Enquête sur la santé des aînés) Services study on mental health and aging. Can J Psychiatry. 2014;59(8):426–33. https://doi.org/10.1177/070674371405900805.
Article PubMed PubMed Central Google Scholar
Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915–20. https://doi.org/10.1093/aje/kwg231.
Essebag V, Platt RW, Abrahamowicz M, Pilote L. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol. 2005;5(1):5. https://doi.org/10.1186/1471-2288-5-5.
Article PubMed PubMed Central Google Scholar
Csizmadi I, Collet JP. Bias and confounding in pharmacoepidemiology. In: Strom BL, Kimmel SE, editors. Textbook of pharmacoepidemiology. 2nd ed. Wiley; 2013. p. 261–75. https://doi.org/10.1002/9781118707999.ch16.
D’Arcy M, Stürmer T, Lund JL. The importance and implications of comparator selection in pharmacoepidemiologic research. Curr Epidemiol Rep. 2018;5(3):272–83. https://doi.org/10.1007/s40471-018-0155-y.
Article PubMed PubMed Central Google Scholar
Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16(3):241–9. https://doi.org/10.1002/pds.1357.
Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167(4):492–9. https://doi.org/10.1093/aje/kwm324.
D’Aiuto C, Lunghi C, Guénette L, et al. Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary care. Int J Geriatr Psychiatry. 2022;37(8):1–12. https://doi.org/10.1002/gps.5780.
Zullo AR, Danko KJ, Moyo P, et al. Prevention, diagnosis, and management of opioids, opioid misuse, and opioid use disorder in older adults. Agency for Healthcare Research and Quality (AHRQ); 2020.https://doi.org/10.23970/AHRQEPCTB37.
Gontijo Guerra S, Berbiche D, Vasiliadis HM. Measuring multimorbidity in older adults: comparing different data sources. BMC Geriatr. 2019;19(1):166. https://doi.org/10.1186/s12877-019-1173-4.
Article PubMed PubMed Central Google Scholar
American Psychiatric Association APA. Diagnostic and statistical manual of mental disorders (DSM). 5th ed. American Psychiatric Publishing; 2013.
Bice T, Boxerman S. A quantitative measure of continuity of care. Med Care. 1977;15(4):347–9. https://doi.org/10.1097/00005650-197704000-00010.
Article CAS PubMed Google Scholar
Cyr MC, Martens AC, Berbiche D, Perreault S, Blais L. Continuity of care in the ambulatory treatment of adolescents with asthma. J Adolesc Health. 2006;39(6):926.e11-926.e17. https://doi.org/10.1016/j.jadohealth.2006.06.013.
Mason M, Cates CJ, Smith I. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2015;(7):CD011090. https://doi.org/10.1002/14651858.CD011090.pub2.
McCance-Katz EF, Sullivan LE, Nallani S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review: drug interactions with methadone and buprenorphine. Am J Addict. 2010;19(1):4–16. https://doi.org/10.1111/j.1521-0391.2009.00005.x.
Article PubMed PubMed Central Google Scholar
World Health Organization (WHO). Medication without harm. World Health Organization (WHO). 2017. https://apps.who.int/iris/handle/10665/255263. Accessed 6 Dec 2022.
Renoux C, Dell’Aniello S, Brenner B, Suissa S. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism. Pharmacoepidemiol Drug Saf. 2017;26(5):554–60. https://doi.org/10.1002/pds.4197.
Article CAS PubMed Google Scholar
Suissa S. Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol. 2008;168(3):329–35. https://doi.org/10.1093/aje/kwn135.
Comments (0)